These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7876467)

  • 1. Immunotherapy in chronic brucellosis. Effect of levamisole and interferon; mechanisms of action and clinical value.
    Printzis S; Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Lagre F; Goulis G
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):679-93. PubMed ID: 7876467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effect of interferon alpha-2b on T lymphocyte transformation and leukocyte migration inhibition in patients with chronic brucellosis.
    Lagra F; Raptopoulou-Gigi M; Orphanou-Koumerkeridou H; Goulis G
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):223-32. PubMed ID: 2621318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-A 2a administration in chronic anergic brucellosis.
    Boura P; Tsapas G; Kountouras J; Zaharioudaki E
    Hepatogastroenterology; 1995; 42(6):919-22. PubMed ID: 8847046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of various methods of therapy of chronic brucellosis].
    Mukovozova LA
    Ter Arkh; 1987; 59(11):93-6. PubMed ID: 3502037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
    Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
    APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The interferon system in chronic brucellosis].
    Dobracki W; Inglot AD; Gładysz A; Dobracka B; Molin I
    Przegl Epidemiol; 1991; 45(4):387-90. PubMed ID: 1841421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice.
    Sislema-Egas F; Céspedes S; Fernández P; Retamal-Díaz A; Sáez D; Oñate A
    Vaccine; 2012 Nov; 30(50):7286-91. PubMed ID: 23026687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice.
    Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P
    Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation and proliferation of T lymphocyte subpopulations in patients with brucellosis.
    Moreno-Lafont MC; López-Santiago R; Paredes-Cervantes V; Estrada-Aguilera A; Santos-Argumedo L
    Arch Med Res; 2003; 34(3):184-93. PubMed ID: 14567397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the major T-cell antigens present in the Brucella melitensis B115 protein preparation, Brucellergene OCB.
    Denoel PA; Vo TK; Weynants VE; Tibor A; Gilson D; Zygmunt MS; Limet JN; Letesson JJ
    J Med Microbiol; 1997 Sep; 46(9):801-6. PubMed ID: 9291893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A repA-based ELISA for discriminating cattle vaccinated with Brucella suis 2 from those naturally infected with Brucella abortus and Brucella melitensis.
    Wang JY; Wu N; Liu WH; Ren JJ; Tang P; Qiu YH; Wang CY; Chang CD; Liu HJ
    Mol Cell Probes; 2014; 28(5-6):251-4. PubMed ID: 24941369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reevaluation of the effect of levamisole in chronic brucellosis: in vitro and in vivo effect on monocyte phagocytosis.
    Boura P; Raptopoulou-Gigi M; Acriviadis E; Goulis G
    J Immunopharmacol; 1984; 6(3):135-46. PubMed ID: 6333466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.
    Al-Mariri A; Tibor A; Mertens P; De Bolle X; Michel P; Godefroid J; Walravens K; Letesson JJ
    Infect Immun; 2001 Aug; 69(8):4816-22. PubMed ID: 11447155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the doxycycline-rifampicin and levamisole combination on lymphocyte subgroups and functions of phagocytic cells in patients with chronic brucellosis.
    Dizer U; Hayat L; Beker CM; Görenek L; Ozgüven V; Pahsa A
    Chemotherapy; 2005 Mar; 51(1):27-31. PubMed ID: 15722630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice.
    Golshani M; Rafati S; Dashti A; Gholami E; Siadat SD; Oloomi M; Jafari A; Bouzari S
    Mol Immunol; 2015 Jun; 65(2):287-92. PubMed ID: 25723468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B. melitensis rough strain B115 is protective against heterologous Brucella spp. infections.
    Adone R; Francia M; Pistoia C; Pesciaroli M; Pasquali P
    Vaccine; 2011 Mar; 29(14):2523-9. PubMed ID: 21300102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection.
    Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH
    Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved serodiagnosis of bovine brucellosis by novel synthetic oligosaccharide antigens representing the capping m epitope elements of Brucella O-polysaccharide.
    McGiven J; Howells L; Duncombe L; Stack J; Ganesh NV; Guiard J; Bundle DR
    J Clin Microbiol; 2015 Apr; 53(4):1204-10. PubMed ID: 25653412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.